Jen Liou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jen Liou has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Tobias Meyer
Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, USA
2 shared publications - Jason W. Myers
Department of Chemical and Systems Biology and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305, USA
1 shared publication - Joshua T Jones
Department of Chemical and Systems Biology and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305, USA
1 shared publication - Man Lyang Kim
Department of Chemical and Systems Biology and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305, USA
1 shared publication - Marc Fivaz
ReMYND NV; Bio-Incubator, Gaston Geenslaan 1, Leuven-Heverlee 3001, Belgium
1 shared publication - Mary. N. Teruel
Department of Biochemistry and Biophysics, Weill Cornell Medicine, New York, NY 10065
1 shared publication
Latest Publications
- Open Access
- 19 July 2007
- Published by Springer Nature in Genome Biology
- Vol. 8 (7) , R142
siRNA screen of the human signaling proteome identifies the PtdIns(3,4,5)P3-mTOR signaling pathway as a primary regulator of transferrin uptake
Background: Iron uptake via endocytosis of iron-transferrin-transferrin receptor complexes is a rate-limiting step for cell growth, viability and proliferation in tumor cells as well as non-transformed cells such as activated lymphocytes. Signaling pathways that regulate transferrin uptake have not yet been identified. Results: We surveyed the human signaling proteome for regulators that increase or decrease transferrin uptake by screening 1,804 dicer-generated signaling small interfering RNAs using automated quantitative imaging. In addition to known transport proteins, we identified 11 signaling proteins that included a striking signature set for the phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3)-target of rapamycin (mTOR) signaling pathway. We show that the PI3K-mTOR signaling pathway is a positive regulator of transferrin uptake that increases the number of transferrin receptors per endocytic vesicle without affecting endocytosis or recycling rates. Conclusion: Our study identifies the PtdIns(3,4,5)P3-mTOR signaling pathway as a new regulator of iron-transferrin uptake and serves as a proof-of-concept that targeted RNA interference screens of the signaling proteome provide a powerful and unbiased approach to discover or rank signaling pathways that regulate a particular cell function.
- 19 July 2007
- Published by Springer Nature in Genome Biology
- Vol. 8 (7) , R142
Open AccesssiRNA screen of the human signaling proteome identifies the PtdIns(3,4,5)P3-mTOR signaling pathway as a primary regulator of transferrin uptake
Background: Iron uptake via endocytosis of iron-transferrin-transferrin receptor complexes is a rate-limiting step for cell growth, viability and proliferation in tumor cells as well as non-transformed cells such as activated lymphocytes. Signaling pathways that regulate transferrin uptake have not yet been identified. Results: We surveyed the human signaling proteome for regulators that increase or decrease transferrin uptake by screening 1,804 dicer-generated signaling small interfering RNAs using automated quantitative imaging. In addition to known transport proteins, we identified 11 signaling proteins that included a striking signature set for the phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3)-target of rapamycin (mTOR) signaling pathway. We show that the PI3K-mTOR signaling pathway is a positive regulator of transferrin uptake that increases the number of transferrin receptors per endocytic vesicle without affecting endocytosis or recycling rates. Conclusion: Our study identifies the PtdIns(3,4,5)P3-mTOR signaling pathway as a new regulator of iron-transferrin uptake and serves as a proof-of-concept that targeted RNA interference screens of the signaling proteome provide a powerful and unbiased approach to discover or rank signaling pathways that regulate a particular cell function.
- Top Cited Papers
- 29 May 2007
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (22) , 9301-9306
Live-cell imaging reveals sequential oligomerization and local plasma membrane targeting of stromal interaction molecule 1 after Ca 2+ store depletion
Stromal interaction molecule 1 (STIM1) has recently been identified by our group and others as an endoplasmic reticulum (ER) Ca 2+ sensor that responds to ER Ca 2+ store depletion and activates Ca 2+ channels in the plasma membrane (PM). The molecular mechanism by which STIM1 transduces signals from the ER lumen to the PM is not yet understood. Here we developed a live-cell FRET approach and show that STIM1 forms oligomers within 5 s after Ca 2+ store depletion. These oligomers rapidly dissociated when ER Ca 2+ stores were refilled. We further show that STIM1 formed oligomers before its translocation within the ER network to ER–PM junctions. A mutant STIM1 lacking the C-terminal polybasic PM-targeting motif oligomerized after Ca 2+ store depletion but failed to form puncta at ER–PM junctions. Using fluorescence recovery after photobleaching measurements to monitor STIM1 mobility, we show that STIM1 oligomers translocate on average only 2 μm to reach ER–PM junctions, arguing that STIM1 ER-to-PM signaling is a local process that is suitable for generating cytosolic Ca 2+ gradients. Together, our live-cell measurements dissect the STIM1 ER-to-PM signaling relay into four sequential steps: ( i ) dissociation of Ca 2+ , ( ii ) rapid oligomerization, ( iii ) spatially restricted translocation to nearby ER–PM junctions, and ( iv ) activation of PM Ca 2+ channels.
- 29 May 2007
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (22) , 9301-9306
Top Cited PapersLive-cell imaging reveals sequential oligomerization and local plasma membrane targeting of stromal interaction molecule 1 after Ca 2+ store depletion
Stromal interaction molecule 1 (STIM1) has recently been identified by our group and others as an endoplasmic reticulum (ER) Ca 2+ sensor that responds to ER Ca 2+ store depletion and activates Ca 2+ channels in the plasma membrane (PM). The molecular mechanism by which STIM1 transduces signals from the ER lumen to the PM is not yet understood. Here we developed a live-cell FRET approach and show that STIM1 forms oligomers within 5 s after Ca 2+ store depletion. These oligomers rapidly dissociated when ER Ca 2+ stores were refilled. We further show that STIM1 formed oligomers before its translocation within the ER network to ER–PM junctions. A mutant STIM1 lacking the C-terminal polybasic PM-targeting motif oligomerized after Ca 2+ store depletion but failed to form puncta at ER–PM junctions. Using fluorescence recovery after photobleaching measurements to monitor STIM1 mobility, we show that STIM1 oligomers translocate on average only 2 μm to reach ER–PM junctions, arguing that STIM1 ER-to-PM signaling is a local process that is suitable for generating cytosolic Ca 2+ gradients. Together, our live-cell measurements dissect the STIM1 ER-to-PM signaling relay into four sequential steps: ( i ) dissociation of Ca 2+ , ( ii ) rapid oligomerization, ( iii ) spatially restricted translocation to nearby ER–PM junctions, and ( iv ) activation of PM Ca 2+ channels.